Method for treating schizophrenia
AssigneeEli Lilly and Company
InventorsCharles H. Mitch, Per Sauerberg, Harlan E. Shannon
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treating a condition selected from the group consisting of schizophrenia, schizoaffective disorder, and schizophreniform disorder in a patient using a Compound (I).
Claims9
A method for treating in a patient suffering from a condition selected from the group consisting of schizophrenia, schizophreniform disorder, and schizoaffective disorder comprising administering to a patient in need thereof, an effective amount of a Compound I:
- wherein
- r represents an integer of 2 to 4, s represents 1 or 2 and t represents 0 or 1;
- R2 is a group OR4, where R4 is C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, a group OCOR5 where R5 is hydrogen or R4;
- and R3 is CN;
- or
- a pharmaceutically acceptable salt or solvate thereof
- or a pharmaceutically acceptable salt thereof.
A method for treating in a patient suffering from a pathologic psychotic condition comprising administering to a patient in need thereof, an effective amount of a Compound I:
- wherein
- r represents an integer of 2 to 4, s represents 1 or 2 and t represents 0 or 1;
- R2 is a group OR4, where R4 is C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, a group OCOR5 where R5 is hydrogen or R4;
- and R3 is CN;
- or
- a pharmaceutically acceptable salt or solvate thereof
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.